US20240157023
2024-05-16
Human necessities
A61L26/0061
Phototunable hydrogels present a novel approach for addressing tissue fibrosis and related conditions by leveraging their unique viscoelastic properties. These hydrogels are composed of a norbornene-functionalized hyaluronic acid (HA) backbone, which may include additional functional moieties such as β-cyclodextrin and adamantane. The hydrogels can incorporate peptides and polypeptide fragments, notably RGD peptides and fibronectin fragments, to enhance cell-instructive properties. This composition allows the hydrogels to manipulate cellular behavior effectively, offering potential therapeutic applications for wound healing and fibrosis inhibition.
The phototunable hydrogels function by modulating biophysical cues such as stiffness, viscoelasticity, and integrin engagement. These cues are critical in influencing fibroblast behavior, including spreading and focal adhesion formation. By adjusting these parameters independently within a single system, the hydrogels can simulate complex tissue environments. This capability is crucial for understanding how different mechanoregulatory signals interact to promote or inhibit fibrogenic activities in cells.
The development of these hydrogels is backed by extensive research into the mechanobiology of tissue fibrosis. Studies have shown that tissue stiffness and viscoelasticity significantly impact fibroblast activation and ECM production. The innovative aspect of this hydrogel system lies in its ability to tune these mechanical properties photochemically, thereby offering a versatile platform for studying cell mechanics and developing therapeutic interventions.
These hydrogels have broad potential applications in medical treatments, particularly in managing fibrosis-related conditions such as lung fibrosis and scarring. By inhibiting myofibroblast formation and reducing the expression of fibrogenic markers like α-SMA, the hydrogels offer a promising strategy for preventing pathological scarring. Moreover, their ability to be precisely tuned makes them suitable for personalized medicine approaches in regenerative therapies.
The development of these phototunable hydrogels has been supported by government funding through a grant from the National Institutes of Health. This support underscores the potential significance of this technology in advancing healthcare solutions. The patent application includes detailed information on the hydrogel's composition and functionality, ensuring protection of the intellectual property while enabling further research and development.